Monoclonal antibodies can help high-risk people with COVID-19. But getting the drug to patients remains challe - The Philadelphia Inquirer

Monoclonal antibodies can help high-risk people with COVID-19. But getting the drug to patients remains challe  The Philadelphia Inquirer